Top 50 Medical Startup Investors in Australia
A list of 50 angel investors and VC funds that invest in Medical startups based in Australia. We rank investors based on the number of investments they made in Medical companies from Australia. We update this investor list every month.Top 50 Medical Startup Investors in Australia
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
- Pathios Therapeutics — Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
- Ohmie Go — EV charging solutions, shared electric vehicles, shared e-bikes & e-scooters delivered to residents as a premium managed service and amenity - An intelligent way to get EV ready with one seamless experience.
- Sova Health — Sova Health is a precision nutrition platform that guides users towards a healthier lifestyle with personalized nutrition advice based on accurate blood biomarker analysis. Understand what is stopping you from achieving your nutritional goal and get your personalized nutrition plan.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro Shatters the Wi-Fi HaLow Range Record... AgainSets New Benchmark in Connectivity with Record 16 km Wi-Fi HaLow Range Watch Now Smarter,
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Funding Round, Series A
- Australia, United States, United Kingdom
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
- Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Series B
- Australia, United States, Philippines
Portfolio highlights
- Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
- Xefco — Xefco is a company that develops novel textile and coating technologies. It uses a global network of research partners to develop advanced manufacturing solutions and apply cutting-edge materials science, with an emphasis on functional enhancements, sustainable manufacturing, and decreased resource consumption.
- Samsara Eco — Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution.
Right Click Capital - Australian Venture Capital Firm
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- Australia, Singapore, United States
Portfolio highlights
- Cydarm — A case management platform that enables cybersecurity operations teams to collaborate, integrate, and respond with ease.
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
- Health Care, Information Technology, SaaS
- Seed, Series A, Funding Round
- Australia, United States, United Kingdom
Portfolio highlights
- Modo — Declutter your mind with our app to boost your mental wellbeing and productivity. modo helps you be present in the moment and focus on what matters most.
- Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
- More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
- SaaS, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- Australia, United States
Portfolio highlights
- Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
- FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
- Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Kurt Alexander
Show more
Investment focus
- Mining, Retail, Medical
- Seed, Funding Round
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
- Software, Financial Services, FinTech
- Funding Round, Series B, Convertible Note
- Australia, United States, United Kingdom
Portfolio highlights
- Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Seed, Series A, Funding Round
- Australia, United States
Portfolio highlights
- OpusXenta — Intuitive software for cemetery, crematory & funeral home management. Easily manage bookings, records, mapping & financials. Request a demo today.
- PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
- FLK It Over — Sign documents online easily with FLK it over. Get started in just 2 minutes with our 14-day free trial. Try it now!
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Series B
- Australia, United States, New Zealand
Portfolio highlights
- Redactive — Redactive.ai is an Enterprise AI enablement platform that accelerates regulated organisations to secure & remediate their operational (unstructured) data, preparing it to be used by AI applications (eg: Co-pilots), along with providing engineering teams inside the enterprise the tools to build their own AI use cases securely with any LLM.
- Aquila — We're powering the future by building and operating an infinitely scalable energy network.
- Vertus Energy — We innovate to make fossil natural gas extinct.
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
- Software, Apps, Information Technology
- Seed, Series A, Funding Round
- Australia, United States, New Zealand
Portfolio highlights
- Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
- HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
- SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more
Investment focus
- Construction, Software, SaaS
- Funding Round, Seed, Convertible Note
- Australia, United States
Portfolio highlights
- SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
- APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
We invest in Western Australian Innovators with bold ideas and global ambitions. We invest at Seed to Series-A in Western Australian companies.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Seed, Series A
- Australia
Portfolio highlights
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more
Investment focus
- EdTech, Medical, Education
- Seed
- Australia
Portfolio highlights
- PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
- IDEA — Welcome to IDEA, an alternative education option for young people aged 15+ who are seeking more than the status quo.
- Andromeda Robotics — Andromeda Robotics is a Melbourne-based startup that designs and builds AI-powered companion robots, with the goal of improving well-being and reducing loneliness, particularly among the elderly and children in hospitals and care centers.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Software
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
- Voyage Foods — Voyage Foods has made sustainable and scalable alternatives to foods that have current obstacles –environmental, social, and health alike. Our breakthrough technology provides endless opportunities to make delicious, nearly identical, versions of beloved foods, without compromising individual health or our planet. We replicated the world’s favoritefoods so that we can all enjoy them, forever.
- Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more
Investment focus
- Software, SaaS, Information Technology
- Series A, Seed, Funding Round
- Australia, New Zealand, United States
Portfolio highlights
- CorePlan — CorePlan is drilling management platform for mining, exploration and drilling companies to digitise their drill program operations. Move from pen, paper and spreadsheets to digital plods, drill planning, rig management, safety compliance and more using our cloud based software.
- Nexl — Nexl believes that CRM systems should be easy-to-use, affordable, and fully automated. They made it their mission to enable law firm's around the world to take back control over their business development efforts and enable them to grow at their full potential.
- InvestorHub — We provide comprehensive access to listed capital raises for institutional, family office and high net worth investors.
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Series A, Series B
- Australia, United States, United Kingdom
Portfolio highlights
- CNaught — CNaught is an online platform that helps companies to purchase a diversified portfolio of carbon offsets.
- NayaOne — Revolutionise your financial institution with NayaOne's Sandbox as a Service platform. Accelerate innovation, reduce risks, and partner with top-tier fintechs.
- Lounge — Use Lounge to organise events and groups in seconds, without a newsfeed. Stop scrolling, start living.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
- Software, Enterprise Software, Information Technology
- Series A, Series B, Funding Round
- United States, Australia, Philippines
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,239,908 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more
Investment focus
- Medical, Health Care, Therapeutics
- Pre-Seed
- Australia
Portfolio highlights
- Psychae Therapeutics — Psychae Therapeutics is a biotechnology company creating transformative psychedelic-assisted therapies that combine the best of nature with modern pharmaceutical science. Our vision is to integrate the profound healing properties of botanical psychedelic substances with rigorous evidence-based medi
Luke & Janelle Roberts
Show more
Investment focus
- Mining, Retail, Medical
- Seed
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed, Pre-Seed
- Canada, Australia
Portfolio highlights
- Skritswap — skritswap software reduces the reading level of information.
- HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more
Investment focus
- Software, Health Care, Machine Learning
- Seed, Funding Round, Series A
- United States, Colombia, India
Portfolio highlights
- Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
- MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
- Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.
Show more
Investment focus
- Information Technology, Hotel, Solar
- Funding Round, Series A, Series C
- Australia, United States, United Kingdom
Portfolio highlights
- Peel Ports — Peel Ports is a unique network of strategically situated ports, terminals, hubs, shipping lines, and state-of-the-art services.
- SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
- Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
HTC Corp is engaged in the design, development, and manufacture of smartphones and tablets in Taiwan.The company offers PDA phones and smartphones for mobile operators and distributors in Europe, the United States, and Asia. These machines are available as HTC devices and as products individually customized for operators and device partners.The company provides its own HTC self-branded products as well as supports operator-branded products and original equipment manufacturer (OEM) partners. It owns Dopod as a subsidiary company and is a member of the Open Handset Alliance.The company’s products are sold under various brand names such as HTC, Dopod, and Qtek and are often rebranded by major telecommunication carriers. Its products also include pocket PC phones (PDA Phone), ultra mobile phones, HTC kovsky (Sony Ericsson XPERIA X1), and HTC dream (T-mobile G1).HTC Corp was founded by Cher Wang and Peter Chou in 1997. It is headquartered in New Taipei City, Taiwan.
Show more
Investment focus
- Virtual Reality, Software, Augmented Reality
- Series A, Seed, Funding Round
- United States, Taiwan, China
Portfolio highlights
- Hexa — Elevate your eCommerce experience with a 3D tech-stack that lets you create, manage, analyze, and distribute your 3D commerce assets.
- Camsense — Camsense focuses on R&D and manufacturing of vision space positioning technology. It provides customers with highly precise sensors with its self-developed core algorithm and chips. Its products can be applied in consumer robots, industrial test, and surgeries.
- Inworld AI — AI for Metaverse
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Series B
- Australia, United States, Singapore
Portfolio highlights
- Lounge — Use Lounge to organise events and groups in seconds, without a newsfeed. Stop scrolling, start living.
- Amber Electric — Join the smart energy revolution. Amber Electric is a new way to buy electricity. Unlike traditional retailers, we pass through the real-time wholesale price, helping you save money and use more renewable power.
- Mindverse — Discover the AI that transforms your life. MindOS boosts productivity, makes suggestions, and perfects your routines. Get an AI memory today.
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A
- Australia
Portfolio highlights
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
SG Hiscock
Show more
Investment focus
- Software, Legal, Medical
- Series A, Funding Round
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- Immediation — Sophisticated video conferencing for dispute resolution and legal practice. Built by Lawyers, for Lawyers. Start your free 14-day trial today.
- Marketplacer — We make it easy for you to integrate third-party seller inventory into your platforms, opening up a world of growth opportunities.
Donald Kirk
Show more
Investment focus
- Mining, Retail, Medical
- Seed
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more
Investment focus
- Medical, Facial Recognition, Artificial Intelligence
- Seed, Funding Round
- Australia
Portfolio highlights
- Strong Room — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.
Show more
Investment focus
- Medical, Software, Health Care
- Series A
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series C, Series B, Series A
- United States, Israel, Australia
Portfolio highlights
- IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
- Evox Therapeutics — Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectualproperty portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families.Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.
- Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines
Jutech Pty Ltd
Show more
Investment focus
- Mining, Retail, Medical
- Seed
- Australia
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
As Australia's national science agency and innovation catalyst, we solve the greatest challenges through innovative science and technology.
Show more
Investment focus
- Software, Agriculture, Health Care
- Series A, Funding Round
- Australia, United States
Portfolio highlights
- Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
- Kasada — Kasada stops automated threats and bot attacks from the very first request across web, mobile apps, and APIs. Real-time bot mitigation with no rules to manage.
- Digital Agriculture Services — SaaS for financial services. Data, imagery, software and CRM integrations decision-makers need to lend, insure, invest, sell and serve customers.
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Show more
Investment focus
- Sensor, Medical, Wearables
- Funding Round
- Australia
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
With origins in owning and operating Australian pharmacies, Soul Patts has evolved into a diversified investment house investing across a range of industries and asset classes, including listed equities, private equity, credit, and property.
Show more
Investment focus
- Software, Hotel, Men's
- Funding Round, Series A
- Australia
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
Telstra Ventures provide venture capital investment in lighthouse technology companies that are commencing scale. Leveraging data science for scaling new business.
Show more
Investment focus
- Software, Information Technology, SaaS
- Series B, Series C, Series A
- United States, China, Australia
Portfolio highlights
- Tabnine — Tabnine is an AI code-completion tool that helps developers worldwide write better code faster.
- Pexapark — We make PPAs for renewables simple. Master your wind and solar power purchase agreements and get the tools to manage merchant risk.
- Super.com — Through rich rewards and everyday savings, Super helps you access more of what you want at better prices, escape overspending, and level up life.
AirTree is a venture capital firm investing in Australian and New Zealand technology founders from seed stage or earlier.
Show more
Investment focus
- Software, Information Technology, SaaS
- Series A, Seed, Series B
- Australia, United States, New Zealand
Portfolio highlights
- Firmable — Firmable is the definitive B2B database in Australia helping businesses drive smarter decisions by knowing more about their leads, customers, and candidates than ever before.
- ProcurePro — Unlock procurement, Enable performance.
- Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
Get Award Winning cover. Voted Outstanding Value Health Insurance for 16 Consecutive Years. Choose from flexible cover options & join online today.
Show more
Investment focus
- Medical, Health Care, Information and Communications Technology (ICT)
- Corporate Round
- Australia
Portfolio highlights
- Medinet — Streamline your medical practice and improve employee wellness with Medinet's comprehensive practice management and corporate health services.
Mr. Li Ka-shing is the richest person of East Asian descent in the world and the 11th richest person in the world with an estimated wealth of US$26 billion (as estimated by Forbes). His primary operating company is Hutchison Whampoa Limited. Mr Li's younger son, Richard, is Chairman of PCCW, one of Asia's leading internet andtelecommunications companies.Mr Li Ka-shing is the Chairman of Cheung Kong (Holdings) Limited and Hutchison Whampoa Limited. Cheung Kong (Holdings) Limited is the flagship of the Cheung Kong Group which has business operations in 54 countries around the world and employs about 240,000 staff. In Hong Kong alone, the Group includes nine listed companies with a combined market capitalization of approximately HKD600 billion (30 June 2009). Hutchison Whampoa Limited is a Fortune Global 500 company.Born in 1928 in Chiu Chow, a coastal city in the southeastern part of China, Mr Li fled to Hong Kong with his family to avoid the perils of war. His father suffered from tuberculosis and passed away in Hong Kong. Shouldering the responsibility of looking after the livelihood of the family, Mr Li was forced to leave school before the age of 15 and found a job in a plastics trading company where he labored 16 hours a day. By 1950, his hard work, prudence and his pursuit of excellence had enabled him to start his own company, Cheung Kong Industries. From manufacturing plastics, Mr Li led and developed his company into a leading real estate investment company in Hong Kong that was listed on the Hong Kong Stock Exchange in 1972. Cheung Kong continued to expand by acquiring Hutchison Whampoa and Hongkong Electric Holdings Limited in 1979 and 1985 respectively.Based in Hong Kong, the Cheung Kong Group's businesses encompass such diverse areas as property development and investment, real estate agency and estate management, hotels, telecommunications and e-commerce, finance and investments, retail, ports and related services, energy, infrastructure projects and materials, media, and biotechnology. Mr Li is a strong believer in synergy — the power of combined efforts. This belief is reflected in his naming his company Cheung Kong Holdings after the Yangtze River that flows through China, a great river that aggregates countless streams and tributaries. The Times in the United Kingdom and Ernst & Young UK jointly named Mr Li as the Entrepreneur of the Millennium at the turn of the century.http://www.hutchison-whampoa.com/eng/about/chairman/chairman.htm 30 June 2009
Show more
Investment focus
- Health Care, Biotechnology, Food and Beverage
- Series A, Series B, Seed
- United States, United Kingdom, Israel
Portfolio highlights
- H2Pro — H2Pro is a renewable energy company that is working on an efficient green hydrogen production method - E-TAC. Its mission is to enable the wide-scale adoption of sustainable hydrogen fuel by introducing a novel water-splitting technology.
- Fertilis — Fertilis: A better way to care for your embryos in an IVF clinic. Fertilis technology involves each embryo growing inside its own patented micro-3D printed pod. The pod protects the embryo and enables automated subtle changes to the nutritive composition of the solutions that bathe the embryo.
- WELL Health Technologies — WELL aims to positively impact health outcomes by leveraging technology to empower and support patients and doctors. Learn about our mission and purpose.
I found a great domain name for sale on Dan.com. Check it out!
Show more
Investment focus
Portfolio highlights
- Gelomics — Gelomics operates as a biotechnology company. Gelomics provides 3D cell culture technologies.
Thorney Opportunities Ltd is an investment company. The Company's principal activity is making investments in listed securities. The Company is focused on producing absolute returns for shareholders over the medium to long-term. Its primary focus is on the selection of investments, which enable it to be a catalyst towards unlocking the valuein the companies that it identifies. The Company's investment manager is Thorney Management Services Pty Ltd.
Show more
Investment focus
- Software, Internet, Artificial Intelligence
- Series A, Funding Round, Series B
- Australia, United States, Israel
Portfolio highlights
- Willed — Willed is an Australian online estate planning platform.
- Earnity — Your new favorite crypto community. Build a portfolio in minutes, copy and share collections, and discuss the latest tokens and research. Create your profile now.
- Buildxact — Buildxact is an easy to use construction management and estimating software designed for small builders and contractors. Sign up for your 14-day free trial.
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- United States, Israel, Australia
Portfolio highlights
- Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
- Capillary Biomedical — Make diabetes management easier with insulin pumps and other innovative products and services from Tandem Diabetes Care.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Stephen Baxter - Founder @ River City Labs
Show more
Investment focus
- Health Care, SaaS, Artificial Intelligence
- Seed, Angel, Pre-Seed
- Australia, United States
Portfolio highlights
- DoseMe — Quick, simple & easy dosing calculator. With DoseMeRx in your EHR, save time & predict the optimal dose of medications with just one blood sample.
- Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
- OrionVM Wholesale Cloud Superstructure — OrionVM is a Wholesale Cloud Infrastructure-as-a-Service (IaaS) company that has developed a revolutionary technology suite (virtual storage, compute, orchestration and virtual networking) to enable the delivery of high performing, highly reliable cloud solutions at market leading price-to-performance ratios. Groundbreaking engineering supportsPublic, Hybrid and Private Cloud deployments and offers an agile system for internal consumption or resale. OrionVM’s Wholesale Cloud Platform provides the best margins, superior performance, and increased technical reliability for resellers and wholesalers of cloud services. OrionVM’s head office is in Sydney, Australia, with U.S. offices also in the San Francisco Bay Area.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Pollenizer is a co-founder of start-up web businesses in Australia. They partner with strong founders and take equity stakes at a concept stage on consumer and SaaS businesses. The skill sets cover technology, marketing and capital raising. They also occasionally make seed investments. Their businesses include;* * ** * * * * * * * * * Their team includes;* Phil Morle, ex-CTO of Kazaa, Omnidrive.* Mick Liubinskas, ex-CMO of Kazaa, Tangler, ZaprThey are also investors and partners with
Show more
Investment focus
- E-Commerce, B2B, Marketplace
- Seed, Angel, Funding Round
- Australia
Portfolio highlights
- LawPath — Create legal documents, manage compliance and connect with lawyers on demand. Less stress, more time and better business. Sign up for free.
- CohortIQ — cohortiQ Home Page
- HiveXchange — Designed and built in Australia for the fresh produce industry. Find opportunities, create private offers, make product requests, get notified of deals in real time. Trade easy.
HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.
Show more
Investment focus
- Solar, Semiconductor, Information Technology
- Series A, Series B, Private Equity
- Australia, United States
Portfolio highlights
- Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
- Morse Micro — Morse Micro Shatters the Wi-Fi HaLow Range Record... AgainSets New Benchmark in Connectivity with Record 16 km Wi-Fi HaLow Range Watch Now Smarter,
- Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
CVC has seven complementary strategies across private equity, secondaries and credit, through which we invest on behalf of pension funds and other leading institutions
Show more
Investment focus
- Software, Financial Services, Retail
- Private Equity, Post-IPO Equity, Funding Round
- United States, United Kingdom, Indonesia
Portfolio highlights
- Odevo — We are on a mission to become the leading force within property management and residential services through the combined power of people and technology. Join us.
- Hempel — We help you protect your most valuable assets with our high-quality coatings
- Sunday Natural — Sunday Natural develops various kinds of organic, plant-based, and healthy products. It offers vitamins, supplements, fruits, vegetables, tea, skincare items and cosmetics that are made with scientific and clinical research. Sunday Natural is based in Berlin, Germany.
Investors by industry
Google
Artificial intelligence
Biotech
Climate
Proptech
Consumer
Media (entertainment)
Hardware
EdTech
Community
Sustainability
Health Care
Agriculture (agtech)
FinTech
Venture Capital
Gaming
Retail
Fashion
Impact
Beauty
Infrastructure
Marketplace
Big Data
Publishing
Energy
Food and Beverage
Organic Food
Art
Real Estate
Photography
B2B
Email
Web3
Oil and Gas
Social Media
Video Games
Wellness
Financial Services
Finance
Social Network
Clean Energy
Payments
Medical
Education
Fitness
Manufacturing
Travel
Internet
Hospitality
Recruiting
Music
Biotechnology
Mobile Advertising
Digital Media
Cannabis
Legal
Platforms
Franchise
Social
Crowdfunding
eSports
Automotive
Wine And Spirits
Local
Medical Device
Android
CleanTech
Transportation
Construction
Mobile Apps
Enterprise Software
InsurTech
Enterprise
Mobile
Sports
LGBT
Film
Theatre
Non Profit
Life Science
SaaS
Renewable Energy
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Blockchain
Cryptocurrency
Facebook
Investors by country
Germany
India
South Korea
Canada
New Zealand
Australia
United Kingdom
Japan
Armenia
Brazil
United States
Africa
LATAM
Ireland
Middle East
Asia
Saudi Arabia
Belize
Europe
Bahrain
Singapore
Spain
Vietnam
Algeria
China
Barbados
Hungary
Oceania
Indonesia
Qatar
South Africa
Sri Lanka
Gibraltar
Kuwait
Lithuania
Mali
Philippines
Costa Rica
Jersey
Myanmar
Ethiopia
Malta
Greece
Mauritius
Nicaragua
Finland
Italy
Liechtenstein
Kenya
Estonia
Cayman Islands
Ghana
Israel
Liberia
Panama
Ecuador
Malaysia
Chile
Lebanon
Kazakhstan
Norway
Egypt
Cambodia
Morocco
Peru
Croatia
Mexico
Tanzania
Zimbabwe
Slovenia
Tunisia
Georgia
Russian Federation
San Marino
Belarus
Ukraine
Faroe Islands
Denmark
Serbia
Venezuela
Thailand
Hong Kong
Zambia
Uzbekistan
Togo
Uruguay
Tajikistan
Senegal
France
El Salvador
Portugal
Sierra Leone
Turkey
Belgium
Poland
Puerto Rico
Taiwan
Bermuda
Seychelles
Bulgaria
Uganda
Rwanda
Czech Republic
Sweden
Dominican Republic
Azerbaijan
Namibia
Nigeria
United Arab Emirates
Iraq
Iceland
Bahamas
Luxembourg
Honduras
Isle of Man
Bolivia
Albania
Pakistan
Cyprus
Bangladesh
Romania
Grenada
Jordan
Argentina
Latvia
Oman
Cameroon
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Australia by industry
Enterprise
FinTech
Consumer
Health Care
EdTech
Biotech
Climate
Impact
Proptech
Community
SaaS
Gaming
Hardware
Restaurants
Crowdfunding
Mobile Apps
Venture Capital
Real Estate
Oil and Gas
Medical Device
Cryptocurrency
Finance
Organic Food
Food and Beverage
Wine And Spirits
Renewable Energy
Medical
Wellness
Video Games
Email
Artificial intelligence
Internet
Media (entertainment)
Social Media
Art
Social Network
Digital Media
Music
Android
Local
Blockchain
Legal
Software
Construction
Enterprise Software
Sports
Fitness
eSports
Hospitality
CleanTech
Automotive
Travel
InsurTech
Recruiting
Cannabis
Biotechnology
Mobile
Retail
Social
Infrastructure
Fashion
Web3
B2B
Beauty
Sporting Goods
Big Data
Publishing
Clean Energy
Financial Services
Non Profit
Energy
Platforms
Education
Manufacturing
Life Science
Marketplace
Payments
Social Impact
Sustainability
Agriculture (agtech)
Transportation